Loading clinical trials...
Loading clinical trials...
Motion Sifnos: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness During Travel
Conditions
Interventions
Tradipitant
Placebo
Locations
1
United States
Vanda Investigational Site
Santa Monica, California, United States
Start Date
December 20, 2018
Primary Completion Date
June 6, 2019
Completion Date
June 27, 2019
Last Updated
May 9, 2025
NCT06056622
NCT04420949
NCT05548270
NCT05628220
NCT04331561
NCT03986905
Lead Sponsor
Vanda Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions